Sign up to save your podcasts
Or
Share What the PATINA Trial Teaches Us About Treating HER2+ Breast Cancer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
What the PATINA Trial Teaches Us About Treating HER2+ Breast Cancer
Drs. Waks and Lynce review the PATINA trial, which showed that adding a CDK4/6 inhibitor to HER2-targeted and endocrine therapy improved progression-free survival in triple-positive breast cancer, shaping how this subgroup may be managed.
View all episodes
By PeerDirect
5
2020 ratings
Drs. Waks and Lynce review the PATINA trial, which showed that adding a CDK4/6 inhibitor to HER2-targeted and endocrine therapy improved progression-free survival in triple-positive breast cancer, shaping how this subgroup may be managed.
More shows like Medical News Podcast
View all
AFP: American Family Physician Podcast
697 Listeners
The Daily
112,835 Listeners
Up First from NPR
56,541 Listeners
Australian Prescriber Podcast
19 Listeners
OncLive® On Air
22 Listeners
Pri-Med Podcasts
87 Listeners
The Journal.
6,060 Listeners
UNBREAKABLE - The OC Podcast
8 Listeners